• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Teladoc Health, Dexcom Offers CGM-Powered Insights to People with Type 2 Diabetes

by Fred Pennic 01/11/2021 Leave a Comment

Teladoc Health, Dexcom Offers CGM-Powered insights to People with Type 2 Diabetes

What You Should Know: - Teladoc Health and Dexcom announced an expanded partnership on a new offering measures the impact of continuous glucose monitoring and real-time health recommendations for people with Type 2 diabetes at no cost. Teladoc Health, Inc., the first and only comprehensive virtual care system, and DexCom, Inc., the leader in real-time continuous glucose monitoring (CGM), today announced that joint Livongo for Diabetes and Dexcom members will now
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

4 Predictions for Diabetes Management and Technology in 2021

by Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec 01/08/2021 Leave a Comment

Is Glucometrics The Missing Data in the Fight Against COVID-19?

Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the result has been the rapid deployment of technology to address dire patient needs. Health systems, physicians, and frontline staff pulled together in remarkable
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Is Glucometrics The Missing Data in the Fight Against COVID-19?

by Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec 09/29/2020 Leave a Comment

Is Glucometrics The Missing Data in the Fight Against COVID-19?

Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients. Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of conditions – whether it’s someone recuperating from a heart attack,
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe

by Fred Pennic 09/28/2020 Leave a Comment

Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe

What You Should Know: - Abbott has received CE Mark (European approval) for its next-generation FreeStyle Libre 3 system for people with diabetes. - FreeStyle Libre 3 is the latest advancement from Abbott’s FreeStyle Libre family of products and featuring the smallest, thinnest continuous glucose monitoring (CGM) sensor (~size of two stacked U.S. pennies) and a more environmentally sustainable system design. Abbott, the worldwide leader in continuous glucose
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Current Health, Dexcom Partner to Deliver Continuous, Remote Glucose Monitoring

by Fred Pennic 07/23/2020 Leave a Comment

Current Health, Dexcom Partner to Deliver Continuous, Remote Glucose Monitoring

What You Should Know: - Current Health has partnered with Dexcom to add continuous glucose monitoring (CGM) capabilities to its remote patient monitoring (RPM) platform – enhancing care and improving outcomes for diabetics. - Dexcom CGM data will transmit directly into the Current Health wearable and platform for review by the care management and clinical teams, improving post-discharge and chronic care of diabetes patients outside the hospital. - Through this partnership, Current
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

One Drop Acquires Sano’s Continuous Glucose Sensing Platform

by Fred Pennic 04/13/2020 Leave a Comment

One Drop Acquires Sano’s Continuous Glucose Sensing Platform

What You Should Know: - One Drop has acquired all the assets and intellectual property of Sano Intelligence, Inc. which include Sano's continuous glucose sensing platform. - One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions. One Drop, a New York City-based provider of digital care solutions for people
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data

by Jasmine Pennic 09/16/2019 Leave a Comment

Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data

- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring

by Fred Pennic 03/28/2019 Leave a Comment

Biolinq Lands $4.75M to Expand Biosensor Patch for Continuous Glucose Monitoring

Biolinq, a San Diego, CA-based digital health company developing a minimally-invasive electrochemical biosensor patch for continuous glucose monitoring (CGM) has raised $4.75 million in Series A funding led by the JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. Existing investors in the round include M Ventures and Hikma Ventures, the corporate venture capital arm of Hikma Pharmaceuticals. The latest round brings Biolinq’s total Series A funding to $15 million.Inception of
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

DarioHealth Integrates Blood Glucose Data with Glytec’s Outpatient Insulin Management Solution

by Jasmine Pennic 03/28/2019 Leave a Comment

diabetes management qualcomm medtronic diabetes

DarioHealth Corp., a blood glucose monitoring system has announced a joint marketing agreement with Glytec, a provider of insulin titration solutions. As part of the partnership, Dario Blood Glucose Monitoring System is now available to hospitals and health systems using Glytec’s virtual insulin titration service for outpatients with diabetes.Integration Details & BenefitsBlood glucose data from the Dario Blood Glucose Monitoring System automatically sent to the Cloud in real-time, will be
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

OptiScan Biomedical Nabs $20M for FDA-Cleared Continuous Glucose Bedside Monitor for ICU

by Fred Pennic 03/20/2019 Leave a Comment

OptiScan Biomedical Nabs $20M for FDA-Cleared Continuous Glucose Bedside Monitor for ICU

OptiScan Biomedical, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU) has raised $20 million in Series E funding. The company plans to use the funding to support the commercialization of the company’s lead product, the OptiScanner 5000, in the United States. OptiScan will also use a portion of the funding to continue the expansion of the company’s OptiScanner platform to monitor additional analytes of interest for critically ill
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]
  • 1
  • 2
  • 3
  • Next Page

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process
  • ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021 COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021
  • FCC COVID-19 Telehealth Program Providers FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |